SAM
REGN icon

Storebrand Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Storebrand Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24M Buy
38,479
+2,540
+7% +$1.73M 0.06% 274
2026
Q1 		$27.8M Buy
35,939
+3,802
+12% +$2.91M 0.08% 231
2025
Q4 		$24.8M Buy
32,137
+3,995
+14% +$2.71M 0.07% 250
2025
Q3 		$15.8M Sell
28,142
-184
-0.6% -$104K 0.04% 318
2025
Q2 		$14.9M Buy
28,326
+928
+3% +$518K 0.04% 336
2025
Q1 		$17.4M Sell
27,398
-21,709
-44% -$14.9M 0.06% 302
2024
Q4 		$35M Sell
49,107
-8,603
-15% -$7.22M 0.11% 192
2024
Q3 		$60.7M Buy
57,710
+2,513
+5% +$2.8M 0.19% 114
2024
Q2 		$58M Sell
55,197
-457
-0.8% -$443K 0.19% 116
2024
Q1 		$53.6M Sell
55,654
-1,363
-2% -$1.3M 0.18% 130
2023
Q4 		$50.1M Sell
57,017
-1,159
-2% -$954K 0.18% 133
2023
Q3 		$47.9M Buy
58,176
+2,503
+4% +$1.97M 0.23% 112
2023
Q2 		$40M Sell
55,673
-5,829
-9% -$4.49M 0.18% 142
2023
Q1 		$50.5M Buy
61,502
+468
+0.8% +$353K 0.26% 100
2022
Q4 		$44M Buy
61,034
+614
+1% +$453K 0.24% 112
2022
Q3 		$41.6M Sell
60,420
-1,211
-2% -$762K 0.25% 103
2022
Q2 		$36.4M Buy
61,631
+583
+1% +$379K 0.21% 122
2022
Q1 		$42.6M Buy
61,048
+6,726
+12% +$4.26M 0.2% 122
2021
Q4 		$34.3M Buy
54,322
+493
+0.9% +$303K 0.15% 155
2021
Q3 		$32.6M Buy
53,829
+13
+0% +$8.07K 0.16% 155
2021
Q2 		$30.1M Sell
53,816
-3,359
-6% -$1.7M 0.15% 167
2021
Q1 		$27.1M Buy
57,175
+3,138
+6% +$1.53M 0.14% 170
2020
Q4 		$26.1M Buy
54,037
+7,288
+16% +$3.93M 0.15% 161
2020
Q3 		$26.2M Buy
46,749
+12,489
+36% +$7.57M 0.19% 122
2020
Q2 		$21.4M Sell
34,260
-528
-2% -$300K 0.18% 132
2020
Q1 		$17M Buy
+34,788
New +$14.3M 0.18% 138

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Storebrand Asset Management's REGN Position: Q2 2026 in Review

Storebrand Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 7.1% in Q2 2026, buying an estimated $1.73M and bringing the position to 38,479 shares worth $24M. The position accounts for 0.06% of the portfolio, ranked #274.

Storebrand Asset Management first reported a position in REGN in Q1 2020 and has held it in 26 quarters since. The position peaked at $60.7M in Q3 2024. 1,256 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Storebrand Asset Management held 38,479 shares of Regeneron Pharmaceuticals worth $24M as of Q2 2026.
  • Storebrand Asset Management bought 2,540 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.73M.
  • Regeneron Pharmaceuticals made up 0.06% of Storebrand Asset Management's portfolio in Q2 2026, its #274 holding.
  • Storebrand Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Storebrand Asset Management's Regeneron Pharmaceuticals position peaked at $60.7M in Q3 2024.
  • 1,256 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.